What is the clinical evidence from this study?

Population: Coronary artery disease. Intervention: ILK deficiency / RIPK1-enriched EVs vs. Wild type / control. Primary outcome: Endothelial activation and cardiac dysfunction.

What does this research mean for the field?

Extracellular vesicles from ILK-deficient endothelial cells, enriched in RIPK1, propagate vascular inflammation and promote cardiac dysfunction in experimental models and human coronary artery disease. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore how ILK deficiency leads to endothelial activation and cardiovascular dysfunction through EV signaling involving RIPK1.

June 24, 2026Journal of Extracellular VesiclesOpen Access

Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling

View Full Paper

Ask AI

Bookmark

Key result

RIPK1-enriched extracellular vesicles from ILK-deficient endothelial cells promote vascular inflammation and cardiac dysfunction.

Key Points

This research aims to explore how ILK deficiency leads to endothelial activation and cardiovascular dysfunction through EV signaling involving RIPK1.
Utilized endothelial-specific ILK conditional knockout mice to examine vascular responses.
In vitro assessment of endothelial cells lacking ILK to evaluate barrier dysfunction and inflammatory signaling.
Analysis of EVs from ILK-deficient cells and their effects on recipient endothelial cells.
ILK deficiency resulted in increased levels of iNOS, VCAM‐1, and ICAM‐1 in endothelial cells, indicating heightened activation.
Transfer of ILK-deficient-derived EVs to wild-type mice induced coronary endothelial activation and cardiac dysfunction.
RIPK1 inhibition or silencing prevented EV-induced endothelial activation, confirming its critical role in the observed effects.

Structured PICO

Population

Endothelial-specific ILK conditional knockout mice, wild type mice, atherosclerotic ApoE-/- mice, in vitro endothelial cells, and patients with coronary artery disease.

Intervention

Transfer of extracellular vesicles (EVs) derived from ILK-deficient endothelial cells; RIPK1 inhibition or silencing.

Comparator

Naïve endothelial cells or wild type mice without pathogenic EV transfer (implied).

Outcome

Endothelial activation, macrophage recruitment, microvascular remodelling, cardiac fibrosis, and ventricular dysfunction.surrogate

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Identifies a novel ILK-RIPK1 signaling axis driving vascular inflammation and cardiac.

Cite This Study

Cook‐Calvete et al. (2026) studied Coronary artery disease. ILK deficiency / RIPK1-enriched EVs vs. Wild type / control was evaluated on Endothelial activation and cardiac dysfunction. Extracellular vesicles from ILK-deficient endothelial cells, enriched in RIPK1, propagated vascular inflammation and promoted cardiac dysfunction in experimental models and human coronary artery disease.

synapsesocial.com/papers/6a3c237ed15afadd906fa37b https://doi.org/10.1002/jev2.70335

Topics

Coronary artery disease

View Full Paper

Ask AI

Bookmark

Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider